Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHSE: 603567)
Health Care · Pharmaceuticals · CN
CN¥5.40
+2.66% today · -54.5% 1Y
Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHSE: 603567) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $756.62M and employs 1,961 people.
Over the last twelve months the share price has lost 54.5%, trading between 4.21 and 12.30.
Tweenvest scores Heilongjiang ZBD Pharmaceutical Co., Ltd. across four factors: quality 58/100, value 50/100, growth 0/100. Its strongest factor is quality.
603567 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $756.62M
- Revenue (TTM)
- $55.84M
- P/E
- —
- EPS
- -1.66
- Dividend yield
- —
- Beta (5Y)
- 0.22
- 52-week high
- CN¥12.30
- 52-week low
- CN¥4.21
- Avg volume (3M)
- —
- Shares outstanding
- 938.50M
- Employees
- 1,961
- Next earnings
- —
About Heilongjiang ZBD Pharmaceutical Co., Ltd.
Heilongjiang ZBD Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm dedicated to the entire lifecycle of Traditional Chinese Medicine (TCM), from research and development to manufacturing and sales, exclusively within China. Its extensive product portfolio addresses a wide spectrum of health concerns, including conditions related to cardiovascular and cerebrovascular health, respiratory ailments, orthopedic issues, oncology, digestive disorders, anti-infective treatments, neuropsychiatric conditions, and genitourinary problems, among others. Established in 1996, the company maintains its headquarters in Hulin, China.
- ISIN
- CNE100002219
- Founded
- 1996
- Listed since
- Apr 24, 2015
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Shandong Jincheng Pharmaceutical Group Co., LtdSZSE: 300233 | $780.40M | CN¥13.78 | +1.32% |
| Center Laboratories, Inc.TPEX: 4123 | $775.56M | NT$31.35 | +0.48% |
| CHO Pharma, Inc.TPEX: 6586 | $773.05M | NT$115.50 | -0.86% |
| Guizhou Sanli Pharmaceutical Co.,LtdSHSE: 603439 | $758.35M | CN¥12.55 | -4.78% |
| DongKook Pharmaceutical Co., Ltd.KOSDAQ: A086450 | $751.63M | ₩22,400.00 | -1.54% |
| Lexicon Pharmaceuticals, Inc.NasdaqCM: LXRX | $747.53M | $1.68 | -7.69% |
| Knight Therapeutics Inc.TSX: GUD | $745.60M | CA$10.83 | +4.94% |
| Shandong Keyuan Pharmaceutical Co., Ltd.SZSE: 301281 | $743.37M | CN¥45.98 | -2.69% |
Figures last refreshed Oct 11, 2026.